Cargando…
Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
Early events in the host response to SARS-CoV-2 are thought to play a major role in determining disease severity. During pulmonary infection, the virus encounters both myeloid and epithelioid lineage cells that can either support or restrict pathogen replication as well as respond with host protecti...
Autores principales: | Hilligan, Kerry L., Namasivayam, Sivaranjani, Clancy, Chad S., O’Mard, Danielle, Oland, Sandra D., Robertson, Shelly J., Baker, Paul J., Castro, Ehydel, Garza, Nicole L., Lafont, Bernard A. P., Johnson, Reed, Ronchese, Franca, Mayer-Barber, Katrin D., Best, Sonja M., Sher, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423217/ https://www.ncbi.nlm.nih.gov/pubmed/34494021 http://dx.doi.org/10.1101/2021.08.30.458273 |
Ejemplares similares
-
Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
por: Hilligan, Kerry L., et al.
Publicado: (2021) -
BCG mediated protection of the lung against experimental SARS-CoV-2 infection
por: Hilligan, Kerry L., et al.
Publicado: (2023) -
Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation
por: Hilligan, Kerry L., et al.
Publicado: (2022) -
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
por: Namasivayam, Sivaranjani, et al.
Publicado: (2023) -
Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
por: Baker, Paul J., et al.
Publicado: (2023)